Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
  1. 4 Exercise or conversion Director acquired 16,233 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 8,116 shares (option exercise)
  3. 4 Planned sale Director sold 5,682 shares at $46.63 ($264,952)
  4. 4 Exercise or conversion Director acquired 16,233 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 12,174 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 4,058 shares (option exercise)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 703 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Legal Officer gave up 5,704 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 5,704 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 4 Shares withheld for taxes President gave up 19,260 shares (to pay taxes)
  12. 4 Planned sale Chief Legal Officer sold 13,885 shares at $52.29 ($726,047)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 5,323 shares (to pay taxes)
  14. 4 Planned sale President sold 160,009 shares at $48.84 ($7,814,840)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 1,278 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Legal Officer gave up 1,334 shares (to pay taxes)
  17. 4 Shares withheld for taxes President gave up 2,362 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 5,450 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 780 shares (to pay taxes)
  20. 4 Open-market sale Director sold 23,853 shares at $29.49 ($703,306)

Page 3 of 54 · 1,067 filings